Neuraxpharm

📍 Sant Joan Despí, Spain👥 575 employees💰 Last funded Jun 2019
Pharmaceutical Manufacturing🌐 neuraxpharm.com
Website LinkedIn
Neuraxpharm is the leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It has a unique understanding and in-depth knowledge of the CNS market built over 35 years. Neuraxpharm is constantly innovating, with new products and solutions to address unmet patient needs and is expanding its portfolio through its pipeline, partnerships and acquisitions. The company has more than 1,000 employees and develops and commercializes CNS products through a direct presence in more than 20 countries in Europe, two in Latin America, and globally via partners in more than 40 countries. Neuraxpharm is backed by funds advised by the global private equity firm, Permira. Neuraxpharm manufactures part of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain. To learn more about Neuraxpharm, please visit https://www.neuraxpharm.com
5
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
4
Denmark
1
Investor activity2016–2019 · investors recorded per year
201632017120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Neuraxpharm?
Neuraxpharm has 5 investors on record on gritt.io.
When did Neuraxpharm last raise funding?
The most recent investment in Neuraxpharm recorded on gritt.io was in June 2019.
What industry is Neuraxpharm in?
Neuraxpharm operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Neuraxpharm based?
Neuraxpharm is headquartered in Sant Joan Despí, Spain.